FightBox is proud to announce that Enfusion, one of Europe’s leading kickboxing and MMA promotions, returns to live action on Sunday the fifth of September starting at 7:15 pm CEST.
Enfusion is back with “Enfusion 102” after a break during the month of August and just two days after the ECE 6 event. FightBox will be showing the “Enfusion Talents” portion of the card, which features five fights, all under kickboxing rules.
In the main event, at welterweight, Enfusion newcomer David “The Headhunter” Dvoracek of the Czech Republic will take on Morocco’s Soufiane “Polar Bear” El Ballouti, who is undefeated under the Enfusion banner with five victories to his credit. While Ballouti is certainly established as a rising star in the promotion and is on quite a winning streak, he will be at a thirteen centimeter height disadvantage. The Czech fighter also has a wide range of striking experience as an amateur kickboxer and MMA fighter and is known for his aggressive style.
Also, in the co-main event, Amir al Amir faces Mohamed “Bugatti” Badih in a middleweight contest. Amir has found success in both the Enfusion and ECE brands and is looking to continue his success against Enfusion debutant Badih who hails from the Naito Gym in Belgium. The full fight card for the evening can be found below.
Fights Shown on FightBox (Enfusion Talents 85 Card)
Welterweight: David Dvoracek (CZ) vs. Soufiane El Ballouti (MOR)
Middleweight: Amir al Amir (IRQ) vs. Mohamed Badih (BEL)
Welterweight: Jimmy van Kuijeren (NL) vs. Damian Ori (NL)
Lightweight: Milton Dokman (SUR) vs. Ismael Ouzgni (MOR)
Featherweight: Billal Hamdoud (ALG) vs. Mohamed Islem (BEL)
Enfusion is a globally recognized combat sports promotional company presenting Enfusion Kickboxing events and Enfusion Cage Events and FightBox is the broadcasting associate for these series of events.
In addition to the live worldwide broadcast on the FightBox HD channel in over 60 countries, the Enfusion coverage will also be available on-line to FilmBox subscribers at www.filmbox.com. Card is subject to change.
